GRI Bio, Inc. Files 8-K with Corporate Amendments
Ticker: GRI · Form: 8-K · Filed: Feb 19, 2025 · CIK: 1824293
Sentiment: neutral
Topics: corporate-governance, filing-amendment, sec-filing
TL;DR
GRI Bio filed an 8-K on Feb 19, 2025, amending bylaws and reporting other events. Watch for shareholder impact.
AI Summary
On February 19, 2025, GRI Bio, Inc. filed an 8-K report detailing several key events. The company announced amendments to its articles of incorporation and bylaws, potentially altering the rights of its security holders. The filing also indicated other events and the submission of financial statements and exhibits, suggesting ongoing corporate activities and disclosures.
Why It Matters
This filing indicates potential changes to GRI Bio's corporate structure and governance, which could impact shareholder rights and the company's operational framework.
Risk Assessment
Risk Level: medium — Amendments to articles of incorporation and bylaws can signal significant changes in corporate governance or shareholder rights, warranting closer examination.
Key Players & Entities
- GRI Bio, Inc. (company) — Registrant
- February 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2223 Avenida de la Playa, Suite 208 (address) — Principal executive offices
- La Jolla, CA 92037 (address) — Principal executive offices
- 001-40034 (identifier) — SEC File Number
- 82-4369909 (identifier) — IRS Employer Identification No.
FAQ
What specific amendments were made to GRI Bio, Inc.'s articles of incorporation and bylaws?
The filing indicates amendments were made, but the specific details of these changes are not provided in the summary text of the 8-K.
What are the 'Other Events' reported by GRI Bio, Inc. on February 19, 2025?
The filing mentions 'Other Events' as an item of disclosure, but the nature of these events is not specified in the provided text.
What is the significance of the 'Financial Statements and Exhibits' being filed?
The filing of financial statements and exhibits suggests that GRI Bio, Inc. is providing updated financial information and supporting documentation as required by the SEC.
When was GRI Bio, Inc. incorporated, and in which state?
GRI Bio, Inc. was incorporated in Delaware, as stated in the filing.
What is the principal executive office address for GRI Bio, Inc.?
The principal executive offices are located at 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding GRI Bio, Inc. (GRI).